Skip to content

US · AKAN · DRUG MANUFACTURERS - SPECIALTY & GENERIC

Akanda Corp. (AKAN) intrinsic value and stock valuation

$4.23as of 2026-11-21 · Mkt cap 162.8K

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Akanda Corp. DCF and intrinsic value

InvestorsCraft values AKAN with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from AKAN’s statements →

Akanda Corp. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Drug Manufacturers - Specialty & Generic New Romney, KE TN28 8XU akandacorp.com

How the business is doing

Fiscal 2019–2025, USD

Revenue
$260K
20192025
Net income
-$-45.65M
20192025
Free cash flow
-$-7.96M
20192025
Total equity
-$-11.99M
20202025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2019–2025, USD
20252024202320222021
Revenue$260K$840K$2.16M$2.62M$40K
Operating income-$-4.98M-$-4.38M-$-10.05M-$-20.18M-$-2.57M
Net income-$-45.65M-$-4.1M-$-32.28M-$-11.66M-$-8.13M
EPSd-$-652.14M-$-205M———
Operating cash flow-$-6.73M-$-3.98M-$-1.5M-$-11.47M-$-6.56M
Capital expenditure-$-1.23M-$-2.1M-$0.00-$-310K-$-580K
Free cash flow-$-7.96M-$-6.08M-$-1.5M-$-11.78M-$-7.13M
Total assets$6.2M$7.91M$8.84M$39M$8.05M
Total debt$14.2M$350K$4M$3.9M$9.57M
Net debt$13.7M-$-3.49M$3.92M$3.67M$6.07M
Total equity-$-11.99M$4.28M-$-3.83M$26.9M-$-2.2M
Cash and short-term investments$500K$3.84M$80K$490K$3.5M
Income statement
20252024202320222021
Revenue$260K$840K$2.16M$2.62M$40K
Cost of revenue$410K$630K$2.05M$650K$760K
Gross profit-$-160K$210K$110K$3.27M-$-710K
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$4.39M$4.45M$5.88M$19.9M$5.81M
Other expenses$430K$140K$4.28M$2.3M$310K
Operating expenses$4.83M$4.59M$10.2M$22.2M$6.12M
Cost and expenses$5.24M$5.22M$12.2M$22.8M$2.61M
Interest income$0.00$10K$0.00$0.00$0.00
Interest expense$930K$100K$260K$120K$10K
Depreciation and amortization$430K$140K$4.28M$3.6M$310K
Ebitda-$-46.01M-$-3.03M-$-27.74M-$-4.52M-$-2.15M
Operating income-$-4.98M-$-4.38M-$-10.05M-$-20.18M-$-2.57M
Total other income/expenses, net-$-42.38M$1.11M-$-22.22M$11.9M$100K
Income before tax-$-47.37M-$-3.27M-$-32.28M-$-8.24M-$-2.47M
Income tax expense$0.00$0.00$0.00$0.00$0.00
Net income-$-45.65M-$-4.1M-$-32.28M-$-11.66M-$-8.13M
Weighted average shares outstanding$70K$20K$0.00$0.00$0.00
Weighted average diluted shares outstanding$70K$20K$0.00$0.00$0.00
Balance sheet
20252024202320222021
Cash and short-term investments$500K$3.84M$80K$490K$3.5M
Net receivables$1.4M$820K$280K$1.24M$240K
Inventory$0.00$0.00$1.29M$1.87M$0.00
Total current assets$3.6M$5.06M$1.81M$3.82M$3.98M
Property, plant and equipment, net$2.59M$2.34M$2.64M$12.5M$3.81M
Goodwill and intangible assets$0.00$20K$3.8M$22.2M$260K
Long-term investments$0.00$500K$590K$0.00$0.00
Total non-current assets$2.59M$2.86M$7.03M$35.2M$4.07M
Total assets$6.2M$7.91M$8.84M$39M$8.05M
Accounts payable$3.31M$2.74M$6.01M$7.14M$680K
Short-term debt$2.25M$350K$1.5M$1.15M$7.59M
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$6.2M$3.64M$10.2M$9.35M$8.27M
Long-term debt$12M$0.00$2.5M$2.75M$1.98M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$12M$0.00$2.5M$2.75M$1.98M
Capital lease obligations$400K$0.00$140K$330K$2.42M
Total liabilities$18.2M$3.64M$12.7M$12.1M$10.3M
Common stock$94.6M$63.3M$51M$49.4M$7.26M
Retained earnings-$-103.09M-$-57.46M-$-53.36M-$-21.09M-$-13.29M
Accumulated other comprehensive income (loss)-$-2.3M-$-1.58M-$-1.49M-$-1.45M$3.84M
Total equity-$-11.99M$4.28M-$-3.83M$26.9M-$-2.2M
Total investments$0.00$500K$590K$260K$0.00
Total debt$14.2M$350K$4M$3.9M$9.57M
Net debt$13.7M-$-3.49M$3.92M$3.67M$6.07M
Cash flow statement
20252024202320222021
Net income-$-46.86M-$-4.1M-$-32.28M-$-11.66M-$-8.13M
Depreciation and amortization$430K$140K$4.28M$3.76M$310K
Stock-based compensation$0.00$0.00$0.00$560K$0.00
Change in working capital-$-2.32M-$-950K$3.15M$2.18M-$-590K
Accounts receivable$70K-$-250K$970K-$-590K-$-240K
Inventory$0.00$370K$480K$500K-$-710K
Accounts payable-$-1.21M-$-730K$1.54M$2.92M$240K
Net cash provided by operating activities-$-6.73M-$-3.98M-$-1.5M-$-11.47M-$-6.56M
Investments in property, plant and equipment-$-1.23M-$-2.1M-$0.00-$-310K-$-580K
Acquisitions, net-$-6.22M$1.45M$0.00-$-3.11M$0.00
Net cash used for investing activities-$-7.45M-$-1.02M$20K-$-4.22M-$-580K
Common stock issued$280K$10.8M$0.00$14.9M$5.05M
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$11.7M$8.99M$1.49M$14.1M$11.2M
Net change in cash-$-3.34M$3.75M-$-160K-$-3.24M$3.48M
Cash at end of period$500K$3.84M$90K$260K$3.5M
Operating cash flow-$-6.73M-$-3.98M-$-1.5M-$-11.47M-$-6.56M
Capital expenditure-$-1.23M-$-2.1M-$0.00-$-310K-$-580K
Free cash flow-$-7.96M-$-6.08M-$-1.5M-$-11.78M-$-7.13M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Akanda Corp.

        Akanda Corp., operating through its various subsidiary entities, focuses on the cultivation, production, and distribution of cannabis products. The company's operations span the United Kingdom, Lesotho, and other global regions, with a specific aim to provide cannabis-derived items for medical and wellness purposes. Formed in 2021, Akanda Corp. is based out of its main office in New Romney, United Kingdom.

        CEO
        Katharyn Field
        Employees
        8
        Beta
        1.73

        Explore

        Frequently asked questions

        What is the intrinsic value of Akanda Corp. (AKAN)?

        InvestorsCraft does not currently publish an intrinsic value for AKAN. How the IC value is calculated.

        Is AKAN undervalued?

        InvestorsCraft does not publish an undervaluation signal for AKAN at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.